Kathleen R. Cho

University of Michigan–Ann Arbor — United States

Medicine · Health Sciences

80h-index27.2kcitations328works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(82), Genetic factors in colorectal cancer(38), Cervical Cancer and HPV Research(35), Endometrial and Cervical Cancer Treatments(35), Cancer Genomics and Diagnostics(31)

Publications326 total

High-grade serous ovarian cancer induced in different sites of origin in mice exemplifies diverse features of the human disease
iScience·2025Open Access
Medroxyprogesterone Acetate Inhibits Tumorigenesis in Mouse Models of Oviductal High-Grade Serous Carcinoma
Cancers·2025Open Access
Bilateral Salpingo-Oophorectomy Is Superior to Salpingectomy Alone in Preventing Non-Tubal Tumor Development in a Mouse Model of High-Grade Serous Carcinoma
Cancers·2025· 1 citedOpen Access
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma
Proceedings of the National Academy of Sciences·2025· 5 citedOpen Access
Abstract 3936: CDK12 tumor suppressor function and therapeutic targeting in newly developed mouse models of serous ovarian cancer
Cancer Research·2025· 1 cited
Abstract 5173: Heterozygous <i>Ppp2r1a</i> mutations with concurrent loss of Tp53 drive invasive high-grade uterine cancer
Cancer Research·2025
SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 induction
Journal of Clinical Investigation·2025· 5 citedOpen Access
Strengthening Asian/Asian American, Native Hawaiian, and Pacific Islander Leadership in Cancer Research
Cancer Discovery·2025· 1 citedOpen Access
DeepDoublet identifies neighboring cell-dependent gene expression
Genomics & Informatics·2024Open Access
Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance
Cell·2024· 40 citedOpen Access
Supplementary Tables S1-10 from Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes
2024Open Access
Data from Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes
2024Open Access
Supplementary Tables S1-10 from Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes
2024Open Access
Supplementary Data from Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes
2024Open Access
Data from Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes
2024Open Access
Supplementary Data from Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes
2024Open Access
Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes
Cancer Research·2023· 24 citedOpen Access
A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors
Gynecologic Oncology·2023· 4 citedOpen Access
A framework for assessing interactions for risk stratification models: the example of ovarian cancer
JNCI Journal of the National Cancer Institute·2023· 3 citedOpen Access
Supplemental Figure 2 from CD24&lt;sup&gt;+&lt;/sup&gt; Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
2023Open Access
page 1 of 17Next →

Frequent Co-authors

Eric R. Fearon(17), Lora Hedrick(13), Rork Kuick(9), Donald R. Schwartz(8), Yali Zhai(7), Nadeem R. Abu‐Rustum(5), Susana M. Campos(5), David E. Cohn(5), Marta A. Crispens(5), Patricia J. Eifel(5), David K. Gaffney(5), Ernest Han(5), Warner K. Huh(5), John R. Lurain(5), David G. Mutch(5), Amanda N. Fader(5), Steven W. Remmenga(5), Nicole R. McMillian(5), Rong Wu(5), Kenneth W. Kinzler(4)